Alveolar Soft Part Sarcoma: Findings from 11 Cases
Author Information
Author(s): Adrien Daigeler, Cornelius Kuhnen, Joerg Hauser, Ole Goertz, Daniel Tilkorn, Lars Steinstraesser, Hans-Ulrich Steinau, Marcus Lehnhardt
Primary Institution: BG-University Hospital Bergmannsheil, Ruhr University Bochum
Hypothesis
The study aims to analyze the clinicopathological features of alveolar soft part sarcoma (ASPS) with a focus on treatment and outcomes.
Conclusion
The study suggests that wide surgical excision and adjuvant radiation are recommended for ASPS, but the prognosis is poor for patients with recurrent disease or metastasis.
Supporting Evidence
- ASPS accounted for 0.7% of soft tissue sarcoma cases in the study.
- Patients with localized disease who underwent complete resection and adjuvant radiation had a positive outcome.
- All patients with distant metastasis had the lungs and brain affected.
Takeaway
This study looked at 11 patients with a rare type of cancer called alveolar soft part sarcoma, finding that surgery and radiation can help, but it's tough to treat if the cancer comes back.
Methodology
The study reviewed 1597 soft tissue sarcoma cases and isolated 11 patients with ASPS, collecting data from patient charts and follow-ups over an average of 6.5 years.
Limitations
The small sample size limits the ability to draw significant conclusions about treatment benefits.
Participant Demographics
Four patients were female, seven were male, with an average age of 32 years (range: 19–49).
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website